Curative Effect of Voriconazole in the Treatment of Patients with Liver Failure Complicated by Pulmonary Fungal Infection  

伏立康唑治疗肝衰竭并发肺部真菌感染患者的疗效

作　　者：LU Mingjiao 

机构地区：[1]Affiliated Hospital of Chengdu University, Chengdu 610081, China

出　　处：《外文科技期刊数据库(文摘版)医药卫生》2021年第1期137-138,共4页

摘　　要：To observe and analyze the efficacy of voriconazole as a drug in the clinical treatment of patients with liver failure complicated by pulmonary fungal infection. Methods: the clinical data of liver failure complicated by pulmonary fungal infection in our hospital from January 2015 to December 2020 were screened, and the appropriate information of 40 patients was selected. According to the different fungal therapy regiments, the patients were divided into experimental group and reference group, with 20 cases in each group. Patients in the reference group were treated with conventional itraconazole as drug treatment, while patients in the experimental group were treated with voriconazole as drug treatment. The treatment effects of the two groups of patients after treatment were observed and compared. Meanwhile, the complications of the two groups were statistically analyzed and compared. Results: according to the statistical results, the therapeutic effect of the reference group was not as good as the experiment group, the difference was great (P < 0.05). However, there was no significant difference in complications between the two groups (P > 0.05). Conclusion: The efficacy of voriconazole in the treatment of patients with liver failure complicated by pulmonary fungal infection is significantly better than that of conventional itraconazole, and there is no serious adverse reaction.

关 键 词：VORICONAZOLE liver failure pulmonary fungal infection ITRACONAZOLE 

分 类 号：R575.3[医药卫生—消化系统] R519[医药卫生—内科学]